ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 36 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $10,115,000 | +1487.9% | 1,935,961 | +1480.3% | 5.25% | +1632.0% |
| Q2 2017 | $637,000 | -83.0% | 122,506 | -86.1% | 0.30% | -85.6% |
| Q1 2017 | $3,752,000 | +13.3% | 882,862 | -16.0% | 2.10% | +8.6% |
| Q4 2016 | $3,311,000 | +45.0% | 1,051,063 | +57.9% | 1.93% | +22.7% |
| Q3 2016 | $2,283,000 | +19.2% | 665,455 | -2.8% | 1.57% | +60.8% |
| Q2 2016 | $1,916,000 | -75.2% | 684,431 | -45.8% | 0.98% | -65.4% |
| Q1 2016 | $7,738,000 | +8.7% | 1,262,330 | -4.3% | 2.83% | -10.2% |
| Q4 2015 | $7,121,000 | +40.8% | 1,318,630 | +0.9% | 3.15% | -9.1% |
| Q3 2015 | $5,058,000 | -1.5% | 1,306,860 | +6.9% | 3.47% | +36.7% |
| Q2 2015 | $5,133,000 | +10.4% | 1,222,260 | +3.6% | 2.54% | -4.2% |
| Q1 2015 | $4,649,000 | -35.5% | 1,179,981 | +1.0% | 2.65% | -53.3% |
| Q4 2014 | $7,210,000 | – | 1,168,566 | – | 5.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Global Strategies LLC | 21,940 | $71,000 | 0.46% |
| Leisure Capital Management | 157,301 | $503,000 | 0.43% |
| BARD ASSOCIATES INC | 759,000 | $2,430,000 | 0.23% |
| Stonebridge Capital Advisors LLC | 32,500 | $104,000 | 0.02% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 63,500 | $203,000 | 0.02% |
| DekaBank Deutsche Girozentrale | 700,000 | $2,240,000 | 0.02% |
| B. Riley Wealth Advisors, Inc. | 21,350 | $69,000 | 0.01% |
| Jacobi Capital Management LLC | 7,421 | $24,000 | 0.01% |
| Patriot Financial Group Insurance Agency, LLC | 1,500 | $5,000 | 0.01% |
| Cable Hill Partners, LLC | 4,000 | $13,000 | 0.01% |